Clinical Trial Results

Showing: All studies [change]
Condition: Multiple Sclerosis 25 trials found
New Search
Filter
Trial Phase
Study Type
Sonification Techniques for Gait Training
NAINTERVENTIONAL Pavia +4 more
RECRUITING
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
PHASE1, PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)
PHASE2INTERVENTIONAL Carlsbad, California +4 more
RECRUITING
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
PHASE1INTERVENTIONAL Stanford, California +4 more
RECRUITING
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
PHASE1INTERVENTIONAL Salt Lake City, Utah +4 more
RECRUITING
The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis
NAINTERVENTIONAL Kütahya, Merkez +4 more
RECRUITING
Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Kinetics Following YTB323 Administration in Participants With Non-active Progressive Multiple Sclerosis (PMS)
PHASE1, PHASE2INTERVENTIONAL Darlinghurst, New South Wales +4 more
RECRUITING
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
PHASE2INTERVENTIONAL New York, New York +4 more
RECRUITING
Neurologic Stem Cell Treatment Study
NAINTERVENTIONAL Westport, Connecticut +4 more
RECRUITING
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis
PHASE4INTERVENTIONAL Kaohsiung +4 more
RECRUITING
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple Sclerosis
PHASE1INTERVENTIONAL Carlsbad, California +4 more
RECRUITING
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
PHASE2INTERVENTIONAL Bethesda, Maryland +4 more
RECRUITING
"Balance, Gait, and Motion Analysis in Multiple Sclerosis"
N/AOBSERVATIONAL Ioannina +4 more
RECRUITING
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
PHASE4INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis
PHASE3INTERVENTIONAL Montpellier +4 more
RECRUITING
Development of Pain Management JITAI Content in Multiple Sclerosis and Spinal Cord Injury
N/AOBSERVATIONAL Ann Arbor, Michigan +4 more
RECRUITING
Gait Adaptation Study
EARLY_PHASE1INTERVENTIONAL Newark, New Jersey +4 more
RECRUITING
Monthly Monitoring of Plasma NfL in Treated Relapsing-remitting Multiple Sclerosis to Detect Persistent Infraclinical Disease Activity
NAINTERVENTIONAL Nice +4 more
RECRUITING
Motor Learning of Fall Resistant Skills Through Slip and Trip Exposure in Multiple Sclerosis
NAINTERVENTIONAL Atlanta, Georgia +4 more
RECRUITING
Cohort Study on Neuroimmune Diseases in the Reproductive Age
N/AOBSERVATIONAL Guangzhou, Guangdong +4 more
RECRUITING
Diagnostic Value of eVOG
NAINTERVENTIONAL Nice +4 more
RECRUITING
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
N/AOBSERVATIONAL Beijing, Beijing +4 more
RECRUITING
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
N/AOBSERVATIONAL New York, New York +4 more
RECRUITING
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
PHASE2INTERVENTIONAL Boston, Massachusetts +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type